SON seeks strengthening of pharmaceutical sector
The Director General, Standards Organisation of Nigeria, Mr Farouk Salim, has canvassed for the strengthening of the pharmaceutical sector in Nigeria, through the development of standards that deal with the peculiar problem.
Salim made this call while delivering the maiden Public Lecture of the Dora Akunyili College of Pharmacy, Igbinedion University, Okada, Edo. The lecture was themed: The Impact of Standards on the Practice of Pharmacy Profession.
He said the call became necessary as standard in the pharmaceutical sector was more crucial given its role in the care of the sick.
“It is the existence of standards, that assures the safety of lives and property, as they establish boundaries and advocate responsibilities.
“In addition, the pharmacy practice in its entirety, both in the clinical and industrial practice has tolerance for error as derived from standards.”
Salim who is also a pharmacist, regretted that only three percent of the drugs in the Nigerian market are produced locally.
“Despite the great potentials for the pharmaceutical industry in Africa with increasing urbanisation, healthcare capacity and supportive business environment as the major drivers of the Africa pharmaceutical market, 95 percent of all medicines produced in Africa are imported with only three percent being produced locally.”
He noted that, SON given its statutory function as the facilitator and enabler of standards and Secretariat of the Standards Council of Nigeria, was critical for the survival of the country’s industrial sector.
Prof. Lawrence Ezemonye, Vice Chancellor of the university, said the event signpost the commitment of the institution to scholastic engagement and community service aimed at strengthening its relationship with society.
He said the management of the university recently awarded a grant of N2.5 million to the College of Pharmacy for research and drug development.
The vice chancellor announced that, the college’s Cancer and Reproductive Research group was currently working on the development of therapeutics useful in easing labour, reducing postpartum haemorrhage and reduction in mother/child mortality/morbidity.
Temitope/NAN
